Cancer Vaccines and Immunotherapy

Cancer vaccines, and immunotherapy represent a transformative frontier in oncology, harnessing the immune system to detect and destroy malignant cells. Cancer vaccines, including preventive and therapeutic types, are being developed to target tumor-specific antigens. Neoantigen -based strategies offer personalized approaches by identifying unique mutations in a patient’s tumor to stimulate a precise immune response. Combining vaccines with checkpoint inhibitors and adoptive cell therapies is enhancing treatment efficacy. Ongoing research aims to improve delivery, reduce resistance, and broaden application across cancer types.

  • HPV and cervical cancer
  • Lung, melanoma & prostate vaccines
  • Immunomodulators
  • Tumor microenvironment research

Related Conference of Cancer Vaccines and Immunotherapy

September 08-09, 2025

45th Global Summit and Expo on Vaccines & Immunology

Frankfurt, Germany
September 18-19, 2025

7th World Congress on Vaccine and Immunology

Amsterdam, Netherlands
October 06-07, 2025

37th Annual Congress on Vaccine and Clinical Trials

Vancouver, Canada
November 19-20, 2025

6th International Conference on Vaccine Research

Tokyo, Japan

Cancer Vaccines and Immunotherapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in